PROF vs VTR · rev $10.7M vs P/E 149, rev $4.92B
Profound Medical Corp (PROF) versus Ventas Inc (VTR) — a side-by-side from cached financials, not a winner call.
Profound Medical Corp (PROF) is a medical devices company listed on NASDAQ.
Ventas Inc (VTR) is a reit - healthcare facilities company listed on NYSE.
Latest reported PROF revenue for 2024-12-31 was $10.7M. Net income was -$27.8M. Revenue was up 48.4% from 2023-12-31 to 2024-12-31. PROF currently screens at market cap $238.7M.
Latest reported VTR revenue for 2024-12-31 was $4.92B. Net income was $88.4M. Revenue was up 9.5% from 2023-12-31 to 2024-12-31. VTR currently screens at market cap $39.94B and trailing P/E 149.4.
PROF currently screens at market cap $238.7M. VTR currently screens at market cap $39.94B and trailing P/E 149.4.
Not investment advice. Open the PROF and VTR stock pages for the full models.
Not investment advice.